IMPACT OF BLOCK SWITCH TO BIOSIMILAR ETANERCEPT IN PRACTICE - AN EXPERIENCE FROM ONE TERTIARY RHEUMATOLOGY DEPARTMENT

被引：0
|
作者：
Brites, Luisa [1 ]
Costa, Flavio [1 ]
de Freitas, Joao Dinis [1 ]
Luis, Mariana [1 ]
Coutinho, Margarida [1 ,2 ]
Santiago, Mariana [1 ,2 ]
Salvador, Maria Joao [1 ,2 ]
Duarte, Catia [1 ,2 ]
Jose Antonio Da Silva, P. [1 ,2 ]
机构：
[1] Ctr Hosp & Univ Coimbra, Rheumatol, Coimbra, Portugal
[2] Fac Med Coimbra, Coimbra, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.1496
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0559
引用
收藏
页码：1372 / 1372
页数：1
相关论文
共 50 条
  • [41] Efficacy and Tolerability of a Biosimilar Infliximab Switch - A Large Single-Centre Experience From the UK
    Bhandare, Anirudh Pramod
    Nigam, Gaurav Bhasker
    Nayeemudin, Shadab
    Limdi, Jimmy K.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S380 - S380
  • [42] Adult onset Still's disease: experience from a tertiary care rheumatology unit
    Reddy Munagala, Vishnu V.
    Misra, Ramnath
    Agarwal, Vikas
    Lawrence, Able
    Aggarwal, Amita
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (06) : E136 - E141
  • [43] Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia
    Anat Fisher
    Jason D. Kim
    Greg Carney
    Colin Dormuth
    [J]. BMC Rheumatology, 6
  • [44] Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis
    Stefano Piaserico
    Andrea Conti
    Francesco Messina
    Alberto Meneguzzo
    Giulia Odorici
    Francesco Bellinato
    Paolo Gisondi
    [J]. BioDrugs, 2021, 35 : 469 - 471
  • [45] Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis
    Piaserico, Stefano
    Conti, Andrea
    Messina, Francesco
    Meneguzzo, Alberto
    Odorici, Giulia
    Bellinato, Francesco
    Gisondi, Paolo
    [J]. BIODRUGS, 2021, 35 (04) : 469 - 471
  • [46] Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France
    Avouac, Jerome
    Molto, Anna
    Abitbol, Vered
    Etcheto, Adrien
    Salcion, Axelle
    Gutermann, Loriane
    Klotz, Caroline
    Elhai, Muriel
    Cohen, Pascal
    Soret, Pierre Antoine
    Morin, Florence
    Conort, Ornella
    Chast, Francois
    Goulvestre, Claire
    Le Jeunne, Claire
    Chaussade, Stanislas
    Kahan, Andre
    Roux, Christian
    Allanore, Yannick
    Dougados, Maxime
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 47 (05) : 741 - 748
  • [47] Use, Safety and Efficacy of Zrc 3197, a Biosimilar Candidate for Reference Adalimumab (Humira) from a Tertiary Pediatric Rheumatology Centre in India
    Agarwal, Manjari
    Shivpuri, Abhay
    Mittal, Sumidha
    Khosla, Amit
    Sawhney, Sujata
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] SWITCH BETWEEN REFERENCE ETANERCEPT (ETN) AND GP2015, AN ETANERCEPT BIOSIMILAR, DID NOT IMPACT EFFICACY AND SAFETY IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: 48-WEEK RESULTS FROM THE PHASE 3 EQUIRA STUDY
    Matucci-Cerinic, M.
    Schulze-Koops, H.
    Buch, M.
    Kavanaugh, A.
    Allanore, Y.
    Kucharz, E. J.
    Babic, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 609 - 609
  • [49] Open Label Transitioning from Originator Etanercept to Biosimilar SB4 Compared to Continuing Treatment with Originator Etanercept in a Historical Cohort in Rheumatic Diseases in Daily Practice
    Tweehuysen, L.
    Huiskes, V. J. B.
    van den Bemt, B. J. F.
    Teerenstra, S.
    van den Hoogen, F. H. J.
    van den Ende, C. H. M.
    Den Broeder, A. A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [50] ONE-YEAR TREATMENT RETENTION AFTER A NATIONWIDE NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR ETANERCEPT IN 2,061 PATIENTS WITH INFLAMMATORY ARTHRITIS FOLLOWED IN THE DANBIO REGISTRY
    Glintborg, B.
    Sorensen, I. J.
    Omerovic, E.
    Mehnert, F.
    Manilo, N.
    Danebod, K.
    Jensen, D. V.
    Nordin, H.
    Loft, A. G.
    Hendricks, O.
    Chrysidis, S.
    Andersen, B. L.
    Raun, J. L.
    Lindegaard, H.
    Espesen, J.
    Jakobsen, S. H.
    Hansen, I. M. J.
    Dalsgaard, E. B.
    Pedersen, D. D.
    Kristensen, S.
    Linauskas, A.
    Andersen, L. S.
    Grydehoj, J.
    Krogh, N.
    Hetland, M. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 313 - 314
12345